Summary by Moomoo AI
Four Circle Pharmaceuticals (4 Circle Pharmaceuticals) filed with Hong Kong Trading and Settlement Limited on 1 March 2024 with Hong Kong Trading and Settlement Limited, reporting the changes in the company's shares for the year ended 29 February 2024. The report showed that the regulated/registered share capital and issued shares of Four Circle Pharmaceuticals remained unchanged in February at HK$1,000,000,000 and 9,329,999,206 shares. In addition, under the share option plan adopted on October 24, 2017, the Company had 74,110,000 shares outstanding at the end of this month and no additional share options were issued. Four Circles Pharmaceuticals confirms that all securities issuance has been approved by the Board of Directors and complies with the relevant requirements of the Listing Rules of the Stock Exchange of Hong Kong Stock Exchange Limited.